Eliminating senescent cells could help treat breast, pancreatic cancers

Shown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could become a new treatment strategy aimed at making immunotherapies and chemotherapies more effective. Credit: Stewart lab Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells—cells that have stopped dividing and drive inflammation—may play important roles in suppressing the immune system and allowing such tumors to grow unchecked. The research, led by Sheila A. Stewart, the Gerty Cori Professor of Cell Read More